In Kingwood, Medicaid providers billed at least $5,125 in 2024 for services identified by HCPCS codes as explicitly COVID-19–related, according to data from the U.S. Department of Health and Human Services Medicaid Provider Spending database.
Medicaid, a joint endeavor funded by federal and state governments and administered by the states, is a public health insurance program that serves low-income individuals and families, as well as seniors, children, and people with disabilities. This program is a major component of the nation’s health care system.
As Medicaid payments come from taxpayer funding, any variation in community billing levels illustrates how public health funds are distributed locally.
COVID-19–related services for this study were captured using HCPCS codes whose billing descriptions or reference classifications included “COVID-19” or “coronavirus.” Therefore, the data reflects only those services directly labeled in billing and does not include pandemic services billed with other or more general codes.
For perspective, South Charleston recorded the highest Medicaid payments for COVID-19 services in West Virginia in 2024, totaling $519,058 in virus-related claims.
Data shows that two providers in Kingwood submitted Medicaid claims for COVID-19–related services in 2024. One of the most used codes, Immunoassay, comprised $3,647 of the total.
On average, Kingwood providers were reimbursed $2,562 each for COVID-19–associated services—a figure below the West Virginia state average of $17,141 per provider.
COVID-19–specific services represented a significant segment of Medicaid spending growth in Kingwood during the years affected by the pandemic.
For comparison, average yearly Medicaid payments in Kingwood during the two years just before the pandemic totaled $4,887,160.
According to the Centers for Medicare & Medicaid Services, combined federal and state Medicaid spending came to approximately $871.7 billion in fiscal year 2023, making up about 18% of all national health expenditures, a significant increase from the $613.5 billion recorded in 2019, prior to the COVID-19 pandemic.
This nearly 40% growth over several years is attributed mainly to increased enrollment and health care usage during and after the pandemic period.
Recent federal budget measures under the Trump administration included major proposals to reduce federal Medicaid funding roles and restructure the program. The “One Big Beautiful Bill Act,” approved in 2025, is expected to reduce federal Medicaid spending by over $1 trillion through the next decade. The law also implements work requirements and greater cost-sharing obligations that may lower both funding and coverage for some recipients, shifting further costs to states and slowing the growth of federal Medicaid support, as Medicaid continues to insure tens of millions of people.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $5,125 | -40.7% | $2,693,218 |
| 2023 | $8,648 | -82.3% | $4,030,567 |
| 2022 | $48,925 | -65.5% | $3,847,453 |
| 2021 | $141,891 | 24% | $4,760,467 |
| 2020 | $114,472 | N/A | $5,962,937 |
| 2019 | $0 | N/A | $3,326,539 |
| 2018 | $0 | N/A | $6,447,781 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $3,647 | 101 |
| 87635 | COVID Specific | $1,478 | 29 |
Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.
Data provided in this report is from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The original data set is available here.


